Treatment of tobacco addiction – a) Nicotine b) Bupropion c) Mecanylate d) Dopamine e) Adenine

**Question:** Treatment of tobacco addiction - a) Nicotine b) Bupropion c) Mecanylate d) Dopamine e) Adenine

**Core Concept:** Tobacco addiction is a complex condition characterized by compulsive tobacco use despite adverse health effects. Nicotine is the primary addictive component in tobacco, while bupropion is a medication used to treat tobacco dependence. Mecanylate is not a commonly used treatment for tobacco addiction, dopamine is a neurotransmitter involved in the reward system, and adenine is an essential nucleotide in DNA synthesis and is not relevant to tobacco addiction.

**Why the Correct Answer is Right:** Nicotine is the primary neurotransmitter in tobacco and is responsible for the addictive properties. Nicotine replacement therapy (NRT) like bupropion aims to reduce nicotine cravings and withdrawal symptoms, helping smokers quit tobacco. Bupropion is an atypical antipsychotic and antidepressant drug that blocks dopamine reuptake, reducing nicotine craving and withdrawal symptoms.

**Why Each Wrong Option is Incorrect:**

- Mecanylate is a nucleoside that is not directly involved in tobacco addiction treatment. It is used in the treatment of some viral infections and does not target nicotine or its effects.
- Dopamine is a neurotransmitter involved in the reward system and motor control, not directly related to tobacco addiction. While reducing dopamine signaling may help with smoking cessation, bupropion is a more effective and direct target for nicotine addiction.
- Adenine is an essential nucleotide in DNA synthesis and RNA, not relevant to tobacco addiction. It is not a medication used in smoking cessation therapy.

**Clinical Pearl:** Understanding the pharmacology of tobacco dependence is crucial for selecting effective treatments like bupropion for nicotine replacement therapy. This can improve patient outcomes and reduce relapse rates in smoking cessation programs.